|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
폐암종류 > 비소세포폐암 > 편평상피세포암 |
|
|
|
|
Total : 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No |
Gene |
CHR |
SNV |
NR/R |
Mutation Type |
Amino Acid |
Strand |
Reference |
|
|
|
|
|
|
1 |
AKT1 |
14q32.3 |
rs121434592 |
C/T |
missense |
p.E17K |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
2 |
B2M |
15q21.1 |
rs1023835002 |
A/G |
start_lost |
p.M1V |
1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
3 |
B2M |
15q21.1 |
rs1023835002 |
A/T |
start_lost |
p.M1L |
1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
4 |
B2M |
15q21.1 |
rs1057519879 |
T/C |
start_lost |
p.M1T |
1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
5 |
B2M |
15q21.1 |
rs1057519879 |
T/G |
start_lost |
p.M1R |
1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
6 |
B2M |
15q21.1 |
rs1057519877 |
G/A |
start_lost |
p.M1I |
1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
7 |
BRAF |
7q34 |
rs121913355 |
C/G |
missense |
p.G469A |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
8 |
BRAF |
7q34 |
rs121913355 |
C/A |
missense |
p.G469V |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
9 |
BRAF |
7q34 |
rs121913355 |
C/T |
missense |
p.G469E |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
10 |
BRAF |
7q34 |
rs121913357 |
C/G |
missense |
p.G469R |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
11 |
BRAF |
7q34 |
rs121913351 |
C/A |
missense |
p.G466V |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
12 |
BRAF |
7q34 |
rs121913351 |
C/T |
missense |
p.G466E |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
13 |
BRAF |
7q34 |
rs121913351 |
C/G |
missense |
p.G466A |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
14 |
CDKN2A |
9p21 |
rs121913386 |
G/A |
missense |
p.P114L |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
15 |
CDKN2A |
9p21 |
rs121913386 |
G/T |
missense |
p.P114H |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
16 |
CDKN2A |
9p21 |
rs104894104 |
G/T |
missense |
p.P114T |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
17 |
CDKN2A |
9p21 |
rs1057519883 |
C/T |
missense |
p.R80Q |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
18 |
CDKN2A |
9p21 |
rs1057519882 |
C/A |
missense |
p.Q50H |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
19 |
CDKN2A |
9p21 |
rs587778189 |
T/C |
missense |
p.Q50R |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
20 |
CREBBP |
16p13.3 |
rs1057519884 |
C/A |
missense |
p.R1446L |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
21 |
CREBBP |
16p13.3 |
rs1057519884 |
C/T |
missense |
p.R1446H |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
22 |
CREBBP |
16p13.3 |
rs398124146 |
G/A |
missense |
p.R1446C |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
23 |
CREBBP |
16p13.3 |
rs398124146 |
G/C |
missense |
p.R1446G |
-1 |
Chang et al., 2016, Nat. Biotechnol. |
|
|
|
|
|
|
24 |
DDR2 |
1q23.3 |
rs144594252 |
C/G |
missense |
p.L63V |
1 |
Hammerman et al., 2011, Cancer Discov |
|
|
|
|
|
|
25 |
DDR2 |
1q23.3 |
rs578015216 |
T/G |
missense |
p.L239R |
1 |
Hammerman et al., 2011, Cancer Discov |
|
|
|
|
|
|
26 |
DDR2 |
1q23.3 |
rs376303676 |
G/T |
missense |
p.G253C |
1 |
Hammerman et al., 2011, Cancer Discov |
|
|
|
|
|
|
27 |
DDR2 |
1q23.3 |
rs115169993 |
G/A |
missense |
p.G505S |
1 |
Hammerman et al., 2011, Cancer Discov |
|
|
|
|
|
|
28 |
DDR2 |
1q23.3 |
rs1057519789 |
A/T |
missense |
p.I638F |
1 |
Hammerman et al., 2011, Cancer Discov |
|
|
|
|
|
|
29 |
DDR2 |
1q23.3 |
rs1057519790 |
G/T |
missense |
p.G774V |
1 |
Hammerman et al., 2011, Cancer Discov |
|
|
|
|
|
|
30 |
EGFR |
7p11.2 |
rs121913428 |
G/A |
missense |
p.G719D |
1 |
Ramalingam et al., 2012, J. Clin.
Oncol. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|